{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-004894","form_type":"8-K","ticker":"ASTH","cik":"0001083446","company_name":"Astrana Health, Inc.","filed_at":"2023-02-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:43.813351+00:00","generated_at":"2026-06-19T01:26:06.644171+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"ApolloMed 2022 revenue $1.14B (+48% YoY), net income $49M, adj. EBITDA $140M","bullets":["Total revenue $1.14B for 2022, up 48% from $773.9M in 2021.","Net income attributable to ApolloMed $49.0M; diluted EPS $1.08.","Adjusted EBITDA $140.0M, up 5% from $133.5M; margin 12.2%.","Cash and equivalents $288.0M at Dec 31, 2022.","Conference call scheduled Feb 24, 2023 at 8:30 a.m. ET."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-004894","json":"https://secwatch.observer/filing/0001628280-23-004894.json","markdown":"https://secwatch.observer/filing/0001628280-23-004894.md","text":"https://secwatch.observer/filing/0001628280-23-004894.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1083446/000162828023004894/0001628280-23-004894-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1083446/000162828023004894/ameh-20230223.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T01:26:06.644171+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b1d6394655859626f9752b8310e2ea008a50ca88","claim":"Astrana Health, Inc. reported the quarter and year ended December 31, 2022 results: revenue $1.14 billion, net income $49.0 million, EPS $1.08.","evidence_excerpt":"• Total revenue of $1.14 billion, an increase of 48% from $773.9 million for the prior year • Net income attributable to ApolloMed of $49.0 million • Earnings per share — diluted (“EPS — diluted”) of $1.08","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1083446/000162828023004894/0001628280-23-004894-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter and year ended December 31, 2022"},{"label":"Revenue","value":"$1.14 billion"},{"label":"Net income","value":"$49.0 million"},{"label":"EPS","value":"$1.08"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}